Register for the DDW Turning Science into Business Summit, ‘Cancer research opportunities and advances’, to hear insight and expertise from leading figures. It will be hosted by DDW and sponsored by Taconic Biosciences.
The event will take place online on 16 November at 7AM PST / 10AM EST / 3PM GMT / 4PM CET and will also be available on-demand.
Register for free to secure your place and to receive your exclusive download link after the event.
The free two-hour summit will outline areas of opportunity in the oncology market and will feature insights from thought leaders in cancer research, precision medicine and immunotherapy.
It will begin with the expert panel discussion on new drug discovery and development concepts and tools in cancer research. Participants include:
- Michael Seiler, Vice President of Commercial Products, Taconic Biosciences
- Spiro Rombotis, CEO, Cyclacel
- Joseph Peterson, CTO & Co-founder, SimBioSys
- Xueming Qian, CEO of Transcenta
Michael Seiler
Spiro Rombotis
Joseph Peterson
Xueming Qian
Thereafter, we will have the following presentations:
- Qasim Ahmad, CMO of IO Biotech, on: ‘The age of therapeutic cancer vaccines – the next frontier in immuno-oncology’
- Andreas Dreps, Senior VP and Global Head of Science, and Muaiad Kittaneh, Senior Director at ICON, on: ‘Research strategies to support the acceleration of oncology antibody drugs to market’.
- Joseph Peterson, CTO & Co-founder, SimBioSys, on: ‘Genomics and personalised medicine: Unlock novel cancer insights with multi-scale data integration’
- Raffi Tonikian, Director, Translational Biomarkers, AbCellera, on: ‘Early integration of biomarker-driven approaches for bispecific development’
Qasim Ahmad
Muaiad Kittaneh
Andreas Dreps Joseph Peterson
Raffi Tonikian
The presentations will be followed by a panel discussion addressing new drug discovery and development concepts and tools in cancer research.
Register for free to secure your place and to receive your exclusive download link after the event.
